SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N HSQC0.5 mM [U-15N] human FK506 binding protein 25 (hFKBP25)-7, 10 % [U-100% 2H] D2O-8, 90 % H2O-9, 50 mM sodium chloride-10, 20 mM sodium phosphate-11, 0.001 % sodium azide-1290% H2O/10% D2O707ambient298
23D HNCA0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
33D HN(CO)CA0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
43D HNCACB0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
53D CBCA(CO)NH0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
63D HNCO0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
73D HN(CA)CO0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
83D C(CO)NH0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
93D H(CCO)NH0.5 mM [U-13C; U-15N] human FK506 binding protein 25 (hFKBP25)-1, 10 % [U-100% 2H] D2O-2, 90 % H2O-3, 50 mM sodium chloride-4, 20 mM sodium phosphate-5, 0.001 % sodium azide-690% H2O/10% D2O707ambient298
103D HNHA0.5 mM [U-15N] human FK506 binding protein 25 (hFKBP25)-7, 10 % [U-100% 2H] D2O-8, 90 % H2O-9, 50 mM sodium chloride-10, 20 mM sodium phosphate-11, 0.001 % sodium azide-1290% H2O/10% D2O707ambient298
113D HCCH-TOCSY0.5 mM [U-13C] human FK506 binding protein 25 (hFKBP25)-13, 100 % [U-100% 2H] D2O-14, 50 mM sodium chloride-15, 20 mM sodium phosphate-16, 0.001 % sodium phosphate-17100% D2O707ambient298
123D 1H-13C NOESY0.5 mM [U-13C] human FK506 binding protein 25 (hFKBP25)-13, 100 % [U-100% 2H] D2O-14, 50 mM sodium chloride-15, 20 mM sodium phosphate-16, 0.001 % sodium phosphate-17100% D2O707ambient298
133D 1H-15N NOESY0.5 mM [U-15N] human FK506 binding protein 25 (hFKBP25)-7, 10 % [U-100% 2H] D2O-8, 90 % H2O-9, 50 mM sodium chloride-10, 20 mM sodium phosphate-11, 0.001 % sodium azide-1290% H2O/10% D2O707ambient298
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE600
2BrukerAVANCE700
NMR Refinement
MethodDetailsSoftware
torsion angle dynamics, simulated annealingTopSpin
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number200
Conformers Submitted Total Number20
Representative Model1 (lowest energy)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBruker Biospin
2processingNMRPipeDelaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3data analysisSparkyGoddard
4refinementCNS